doi toshihiko 土井俊彦

… Alternative Names

Researcher Number	20522907
Other IDs
Affiliation (Current)	2022: 国立研究開発法人国立がん研究センター, 東病院, 科長
Affiliation (based on the past Project Information) *help	2017 – 2021: 国立研究開発法人国立がん研究センター, 東病院, 科長 2016: 国立がん研究センター先端医療開発センター免疫TR分野, 先端医療科長
Review Section/Research Field	Except Principal Investigator Tumor biology / Gastroenterology / General surgery / Tumor therapeutics
Keywords	Except Principal Investigator 免疫学 / 腫瘍浸潤リンパ球 / 癌 / CD8陽性T細胞 / 発がん / 免疫制御 / 腫瘍免疫 / がん免疫療法 / 制御性T細胞 / Human immunology … More

Association of immune responses with racial differences of cancer development
- Principal Investigator
  
  Nishikawa Hiroyoshi
- Project Period (FY)
  2017 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (S)
- Research Field
  
  Tumor biology
- Research Institution
  Nagoya University
トリプルネガティブ乳癌における免疫能を評価する新規亜分類と臨床的有用性の研究
- Principal Investigator
  
  古川孝広
- Project Period (FY)
  2017 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  National Cancer Center Japan
Immunosuppressive mechanisms for anti-tumor immune responses depending on antigenicity
- Principal Investigator
  
  西川博嘉
- Project Period (FY)
  2017
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Nagoya University
Identification of new molecule for regulatory T cells in an anti-tumor immunity
- Principal Investigator
  
  Sugiyama Daisuke
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Gastroenterology
- Research Institution
  Nagoya University
  National Cancer Center Japan

All 2018

All Journal Article Presentation

[Journal Article] Targeting VEGFR2 with Ramucirumab strongly impacts effector/activated regulatory T cells and CD8+ T cells in the tumor microenvironment.J.2018
- Author(s)
  Tada Yasuko、Togashi Yosuke、Kotani Daisuke、Kuwata Takeshi、Sato Eichi、Kawazoe Akihito、Doi Toshihiko、Wada Hisashi、Nishikawa Hiroyoshi、Shitara Kohei
- Journal Title
  
  J Immunother Cancer
  
  Volume: 6 Pages: 106-106
- DOI
  10.1186/s40425-018-0403-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K18388, KAKENHI-PROJECT-17H06162
[Journal Article] Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer2018
- Author(s)
  Kawazoe Akihito、Shitara Kohei、Kuboki Yasutoshi、Bando Hideaki、Kojima Takashi、Yoshino Takayuki、Ohtsu Atsushi、Ochiai Atsushi、Togashi Yosuke、Nishikawa Hiroyoshi、Doi Toshihiko、Kuwata Takeshi
- Journal Title
  
  Gastric Cancer
  
  Volume: 22 Pages: 69-76
- DOI
  10.1007/s10120-018-0843-9
- NAID
  40021775208
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07007, KAKENHI-PROJECT-17K18388, KAKENHI-PROJECT-17H06162
[Presentation] Association of gut microbiome with immune status and clinical response in solid tumor patientswho received on anti-PD-12018
- Author(s)
  Shota Fuoka,Motooka Daisuke, Yosuke Togashi,Eri Sugiyama,Hibiki Udagawa,Keisuke Kirita,Takahiro Kamada,Akihito Kawazoe,Koichi Goto,Toshihiko Doi,Kohei Shitara,Shota Nakamura,Hiroyoshi Nishikawa
- Organizer
  2018 ASCO ANNUAL MEETING
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H06162
[Presentation] An open label phase I study to evaluate the safety and efficacy of OBP-301 with permbrolizumab in patients with advanced solid tumors2018
- Author(s)
  TakashiKojima,Toshiyoshi Fujiwara,Yasuhiro Shirakawa,Hiromi Ono,Masako Nakamoto,Hiromi Hasegawa,Nami Hirano, Masashi Wakabayashi,Shogo Nomura,Yosuke Togashi,Hiroyoshi Nishikawa,Akihiro Sato,Atsushi Ohtsu,Toshihiko Doi
- Organizer
  2018 ASCO ANNUAL MEETING
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H06162

1. Nishikawa Hiroyoshi (10444431)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
2. Sugiyama Daisuke (90759375)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 河野隆志 (80280783)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. 古川孝広 (70444916)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 設楽紘平 (20730419)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
6. 藤井誠志 (30314743)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 原野謙一 (80627258)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 内藤陽一 (90590373)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 冨樫庸介

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
10. 桑田健

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

doi toshihiko 土井 俊彦

Doi Toshihiko 土井 俊彦

Research Projects

Research Products

Co-Researchers

Association of immune responses with racial differences of cancer development

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

トリプルネガティブ乳癌における免疫能を評価する新規亜分類と臨床的有用性の研究

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Immunosuppressive mechanisms for anti-tumor immune responses depending on antigenicity

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of new molecule for regulatory T cells in an anti-tumor immunity

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Targeting VEGFR2 with Ramucirumab strongly impacts effector/activated regulatory T cells and CD8+ T cells in the tumor microenvironment.J.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer2018

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] Association of gut microbiome with immune status and clinical response in solid tumor patientswho received on anti-PD-12018

Author(s)

Organizer

Data Source

[Presentation] An open label phase I study to evaluate the safety and efficacy of OBP-301 with permbrolizumab in patients with advanced solid tumors2018

Author(s)

Organizer

Data Source

doi toshihiko 土井俊彦

Doi Toshihiko 土井俊彦